Upfront Matched Unrelated Donor Transplantation in Aplastic Anemia.
Clesham K, Dowse R, Samarasinghe S.
Hematol Oncol Clin North Am. 2018 Aug;32(4):619-628. doi: 10.1016/j.hoc.2018.03.004. Epub 2018 May 28.
Matched unrelated donor transplants-State of the art in the 21st century.
Altaf SY, Apperley JF, Olavarria E.
Semin Hematol. 2016 Oct;53(4):221-229. doi: 10.1053/j.seminhematol.2016.07.002. Epub 2016 Jul 25.
Expanding post-transplant cyclophosphamide to matched unrelated donor transplants and beyond.
Gooptu M, Bolaños-Meade J, Koreth J.
Blood Rev. 2023 Nov;62:101053. doi: 10.1016/j.blre.2023.101053. Epub 2023 Feb 3.
Guidelines for the diagnosis and management of adult aplastic anaemia: A British Society for Haematology Guideline.
Kulasekararaj A, Cavenagh J, Dokal I, Foukaneli T, Gandhi S, Garg M, Griffin M, Hillmen P, Ireland R, Killick S, Mansour S, Mufti G, Potter V, Snowden J, Stanworth S, Zuha R, Marsh J; BSH Committee.
Br J Haematol. 2024 Mar;204(3):784-804. doi: 10.1111/bjh.19236. Epub 2024 Jan 21.
Haploidentical Versus Matched Unrelated Donor Transplants Using Post-Transplantation Cyclophosphamide for Lymphomas.
Mussetti A, Kanate AS, Wang T, He M, Hamadani M, Finel H Sr, Boumendil A Sr, Glass B, Castagna L, Dominietto A, McGuirk J, Blaise D, Gülbas Z, Diez-Martin J, Marsh SGE, Paczesny S, Gadalla SM, Dreger P, Zhang MJ, Spellman SR, Lee SJ, Bolon YT, Sureda A.
Transplant Cell Ther. 2023 Mar;29(3):184.e1-184.e9. doi: 10.1016/j.jtct.2022.11.028. Epub 2022 Dec 25.
Post-transplantation Cyclophosphamide: From HLA-Haploidentical to Matched-Related and Matched-Unrelated Donor Blood and Marrow Transplantation.
Williams L, Cirrone F, Cole K, Abdul-Hay M, Luznik L, Al-Homsi AS.
Front Immunol. 2020 Apr 9;11:636. doi: 10.3389/fimmu.2020.00636. eCollection 2020.
Unmanipulated haploidentical donor and matched unrelated donor hematopoietic stem cell transplantation in patients with paroxysmal nocturnal hemoglobinuria: a single-center study.
Lu Y, Zhao YL, Xiong M, Sun RJ, Cao XY, Wei ZJ, Lu DP.
Leuk Lymphoma. 2022 May;63(5):1211-1219. doi: 10.1080/10428194.2021.2015588. Epub 2021 Dec 16.
Younger haploidentical donor versus older matched unrelated donor for patients with AML/MDS.
Marcoux C, Marin D, Ramdial J, AlAtrash G, Alousi AM, Oran B, Kebriaei P, Popat UR, Rezvani K, Champlin RE, Shpall EJ, Mehta RS.
Am J Hematol. 2023 May;98(5):712-719. doi: 10.1002/ajh.26870. Epub 2023 Feb 13.
Haploidentical stem cell transplantation vs matched unrelated donor transplantation in adults with hematologic malignancies: a systematic review and meta-analysis.
Ma L, Han X, Jiang S, Meng Q, Zhang L, Bao H.
Hematology. 2020 Dec;25(1):356-365. doi: 10.1080/16078454.2020.1831292.
The use of haploidentical stem cell transplant as an alternative donor source in patients with decreased access to matched unrelated donors.
Graham C, Litzow M.
Hematology. 2024 Dec;29(1):2338300. doi: 10.1080/16078454.2024.2338300. Epub 2024 May 16.
